技術指標
指標
數值
方向
MACD(12,26,9)
-0.374
中性
RSI(14)
50.377
中性
STOCH(KDJ)(9,3,3)
71.487
中性
ATR(14)
2.476
低波動
CCI(14)
21.101
中性
Williams %R
40.940
買入
TRIX(12,20)
0.004
賣出
StochRSI(14)
0.000
賣出
搜尋
LivaNova PLC
LIVN添加自選
80.140USD
-0.910-1.12%
收盤 07-31 16:00（美東）報價延遲15分鐘
4.40B總市值
40.53本益比TTM
關鍵數據
80.560今開
81.780最高
514.70K成交量
40.53本益比TTM
16.87本益比動
--股利TTM
0.94%換手率
81.050昨收
79.294最低
30.95M成交額
69.58本益比靜
3.63市淨率
0.00%股息率 TTM
4.22%ROA
75.81552週最高
0.96量比
63.23M淨利潤
54.90M總股本
1.9772每股盈餘TTM
0.87Beta
9.54%ROE
41.01552週最低
3.07%振幅
67.29%毛利率
4.40B總市值
-1.85回報/風險
1.92%風險率
TradingKey LivaNova PLC股票評分
單位: USD 更新時間: 2026-07-31操作建議
LivaNova PLC當前公司基本面數據相對非常健康，增長潛力很大。當前估值合理，在醫療設備與耗材行業排名22/199位。機構持股佔比非常高，近一月多位分析師給出公司評級為買入。最高目標價為84.93。中期看，股價處於上升通道。近一個月，市場表現一般，但基本面評分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
LivaNova PLC評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
中性
LivaNova PLC亮點
亮點風險
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
業績高增長
公司營業收入穩步增長，連續3年增長20.33%
業績轉虧
公司業績轉虧，最新年度虧損美元
估值合理
公司最新PE估值40.53，處於3年歷史合理位
機構減倉
最新機構持股60.49M股，環比減少15.69%
Hotchkis & Wiley持倉
明星投資者Hotchkis & Wiley持倉，最新持倉478.62K股
活躍度降低
近期活躍度降低，過去20天平均換手率-0.16
分析師目標
基於
10
分析師
買入
評級
84.933
目標均價
+4.30%
漲幅空間
LivaNova PLC新聞
即將為您帶來更多新聞，敬請期待。 。 。
收益預測
分析師評級
基於
10
分析師
買入
評級
84.933
目標均價
+4.30%
漲幅空間
強力買入
買入
持有
賣出
強力賣出
同行比較
109
總數
7
中位數
9
平均值
公司名稱
評級分佈
分析師數
LivaNova PLC
LIVN
10
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Medtronic PLC
MDT
31
Zimmer Biomet Holdings Inc
ZBH
31
亞培
ABT
29
1
2
3
...
22
技術指標
移動平均線
指標
數值
方向
MA5
81.058
賣出
MA10
79.942
買入
MA20
80.931
賣出
MA50
78.791
買入
MA100
71.627
買入
MA200
66.461
買入
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
LivaNova PLC簡介
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
公司代碼LIVN
公司LivaNova PLC
CEOMakatsaria (Vladimir A)
網址https://www.livanova.com/
公司股東
相關品種
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
+0.10%
-6.42%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%
-0.78%熱門品種
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
常見問題
LivaNova PLC(LIVN)的當前股價是多少？
LivaNova PLC(LIVN)的當前股價是 80.14。
LivaNova PLC 的股票代碼是什麼？
LivaNova PLC的股票代碼是LIVN。
LivaNova PLC股票的52週最高點是多少？
LivaNova PLC股票的52週最高點是75.81。
LivaNova PLC股票的52週最低點是多少？
LivaNova PLC股票的52週最低點是41.02。
LivaNova PLC的市值是多少？
LivaNova PLC的市值是4.40B。
現在LivaNova PLC(LIVN)的股票是買入、持有還是賣出？
根據分析師評級，LivaNova PLC(LIVN)的總體評級為買入，目標價格為84.93。
LivaNova PLC(LIVN)股票的每股收益（EPS TTM）是多少
LivaNova PLC(LIVN)股票的每股收益（EPS TTM）是-4.45。